Response to Comments: MolDX: Molecular Testing for Risk Stratification of Thyroid Nodules

This document (A59825) records responses to public comments on the MolDX Local Coverage Determination L39720 for molecular testing for risk stratification of thyroid nodules. The LCD comment period ran 09/28/2023–11/11/2023; the notice period begins 06/13/2024 and the LCD becomes effective 07/28/2024. No coverage, limitation, documentation, or frequency criteria are specified in this response notice.